NL-OMON35463已完成不适用
Efficacy of a mouthrinse containing Ardox-X® Technology on the inhibition of de novo dental plaque formation in vivo - Ardox-X® Technology
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •>= 18 years • Systemically healthy • minimum of 5 teeth per quadrant • absence of oral lesions • not participate in other clinical care study • Overnight plaque assessment of Modified Quigley & Hein index score >=2 • No orthodontic appliances (except for retention lingual wire) • No removable (partial) dentures • No prosthetics crowns • No overhanging margins • Signed written-informed consent
排除标准
- •The use of antibiotics during the last 6 months • Dutch Periodontal Screening Index (DPSI) >=3+ • Use of medication possibly influencing normal gingival health • Pregnancy • Smoking • The use of electric toothbrush
研究者
相似试验
招募中
不适用
Efficacy of a mouthrinse containing Ardox-X® Technology on the inhibition of de novo dental plaque formation in vivo.Ardox-X® Technology, novo plaqueNL-OMON25700ACTA Dental Research B.V.50
尚未招募
不适用
Effectiveness of mouth rinses containing essential oil to reduce gingivitis and plaque in visual impairment children: A randomized controlled trialreduce gingivitis and plaque in visual impairment childrenmouth rinsesPlaqueGingivitisTCTR20170621001Faculty of Dentistry, Prince of Songkla university70
已完成
不适用
A clinical trial to study the effect of periodontal treatment on rheumatoid arthritis diseaseCTRI/2017/01/007713Divvi Anusha40
进行中（未招募）
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prevention of alveolar osteitis after third molar extractionMedDRA version: 18.0 Level: PT Classification code 10066995 Term: Alveolar osteitis System Organ Class: 10021881 - Infections and infestationsEUCTR2014-004682-24-FRPIERRE FABRE MEDICAMENT409
进行中（未招募）
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.EUCTR2014-004682-24-EEInstitut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre414